Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis

Fan Z, Liu X, Liu J, Chen C, Zhou M.

J Integr Neurosci. 2023 Jun 30;22(4):85. doi: 10.31083/j.jin2204085.

Tear biomarkers for Alzheimer's disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study

van de Sande N, Ramakers IHGB, Visser PJ, Verhey FRJ, Verbraak FD, Bouwman FH, Berendschot TTJM, Nuijts RMMA, Webers CAB, Gijs M.

BMC Neurol. 2023 Aug 5;23(1):293. doi: 10.1186/s12883-023-03335-y.

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study

Hong YJ, Ho S, Jeong JH, Park KH, Kim S, Wang MJ, Choi SH, Yang DW; CoSCo study group.

Alzheimers Res Ther. 2023 Aug 7;15(1):132. doi: 10.1186/s13195-023-01273-y.

Obstructive sleep apnea and dementia: A role to play?

Kinugawa K.

Rev Neurol (Paris). 2023 Oct;179(7):793-803. doi: 10.1016/j.neurol.2023.08.006. Epub 2023 Aug 24.

Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence

Amidfar M, Askari G, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110848. doi: 10.1016/j.pnpbp.2023.110848. Epub 2023 Aug 25.

Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis

Gaur A, Rivet L, Mah E, Bawa KK, Gallagher D, Herrmann N, Lanctôt KL.

Ageing Res Rev. 2023 Nov;91:102046. doi: 10.1016/j.arr.2023.102046. Epub 2023 Aug 28.

Bibliometric review on biomarkers for Alzheimer's disease between 2000 and 2023

Yang X, Qu H.

Medicine (Baltimore). 2023 Sep 8;102(36):e34982. doi: 10.1097/MD.0000000000034982.

Tear Biomarkers and Alzheimer's Disease

Kaštelan S, Braš M, Pjevač N, Bakija I, Tomić Z, Pjevač Keleminić N, Gverović Antunica A.

Int J Mol Sci. 2023 Aug 30;24(17):13429. doi: 10.3390/ijms241713429.

Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)

Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, Zeltzer E, Windon CC, Soleimani-Meigooni DN, Tanner JA, Heath CL, Lesman-Segev OH, Aisen P, Eloyan A, Lee HS, Hammers DB, Kirby K, Dage JL, Fagan A, Foroud T, Grinberg LT, Jack CR, Kramer J, Kukull WA, Murray ME, Nudelman K, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski EJ, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Koeppe R, Iaccarino L, Dickerson BC, La Joie R, Rabinovici GD; LEADS Consortium.

Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S98-S114. doi: 10.1002/alz.13453. Epub 2023 Sep 10.

The potential clinical value of plasma biomarkers in Alzheimer's disease

Blennow K, Galasko D, Perneczky R, Quevenco FC, van der Flier WM, Akinwonmi A, Carboni M, Jethwa A, Suridjan I, Zetterberg H.

Alzheimers Dement. 2023 Dec;19(12):5805-5816. doi: 10.1002/alz.13455. Epub 2023 Sep 11.

Anti-amyloid antibody treatments for Alzheimer's disease

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.

Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.

The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022

Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin A, Shaw LM, Toga AW, Tosun D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.

From Clinical Trials to Memory Clinics, Tau-PET Visual Reads Can Help Diagnosis and Patient Stratification

Malpetti M, Rabinovici GD.

Neurology. 2023 Nov 7;101(19):813-814. doi: 10.1212/WNL.0000000000207935. Epub 2023 Sep 25.

Neuroprotective factors affect the progression of Alzheimer's disease

Liu Y, Tian J.

Biochem Biophys Res Commun. 2023 Nov 12;681:276-282. doi: 10.1016/j.bbrc.2023.09.042. Epub 2023 Sep 19.

Toward Prevention and Reduction of Alzheimer's Disease

González-Madrid A, Calfío C, González A, Lüttges V, Maccioni RB.

J Alzheimers Dis. 2023;96(2):439-457. doi: 10.3233/JAD-230454.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias